Mesalazine (Systemic)
National NHS prescribing (Prescription Cost Analysis) · Chronic bowel disorders
Mesalazine (Systemic) was ranked 154th of 1,794 medicines by items in March 2026, with 136,369 items, up 3.3% on a year earlier.
136,369items
Dispensed in March 2026
NHSBSA Prescription Cost Analysis
£7,840,163
Net ingredient cost · March 2026
NHSBSA PCA
1,626,325items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Mesalazine (Systemic): national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to March 2026
Embed this chart
Top presentations, March 2026
The individual products dispensed under Mesalazine (Systemic), by items this month.
| Presentation | Items | Net ingredient cost |
|---|---|---|
| Octasa 800mg MR gastro-resistant tablets | 36,672 | £2,257,157 |
| Octasa 400mg MR gastro-resistant tablets | 20,568 | £709,086 |
| Mezavant XL 1200mg tablets | 11,545 | £830,526 |
| Pentasa 500mg modified-release tablets | 11,373 | £554,113 |
| Pentasa 1g modified-release tablets | 9,550 | £587,001 |
| Mesalazine 1g suppositories | 5,012 | £250,569 |
| Pentasa 2g modified-release granules sachets | 4,968 | £368,262 |
| Salofalk 3g gastro-resistant modified-release gran sachets | 4,957 | £378,240 |
| Asacol 800mg MR gastro-resistant tablets | 4,258 | £348,467 |
| Octasa 1600mg MR gastro-resistant tablets | 2,857 | £222,185 |
| Pentasa 1g suppositories | 2,809 | £136,599 |
| Salofalk 1.5g gastro-resistant modified-release gran sachets | 2,791 | £140,999 |
| Pentasa 1g modified-release granules sachets | 2,709 | £148,504 |
| Salofalk 1g suppositories | 1,878 | £68,405 |
| Salofalk 1g/application foam enema | 1,679 | £114,374 |
Compare Mesalazine (Systemic) with
Other medicines in the same BNF section, by prescribing volume.